The most noteworthy discovery is that we identified nine essential hub candidate genes (MAD2L2, IMP4, PRPF4, CHSY1, SLC20A1, SLC9A1, TIPRL, DPYD, and MAPKAPK2) and developed a diagnostic model for diagnosing AD in MS patients. This evidence concerns the gene DPYD and myeloid sarcoma.